Universiteit Maastricht

At Universiteit Maastricht, research in neoplasms focuses on non-small cell lung cancer, with clinical trials aimed at improving outcomes for people whose disease has already been treated. The work is centered on evaluating a new cancer therapy against an established treatment to better understand its impact on survival and disease control.

• Study of non-small cell lung cancer in previously treated patients
• Assessment of treatment effectiveness for overall survival and disease progression
• Research into pulmonary diseases with an oncology focus

These trials reflect the site’s interest in refining lung cancer care through evidence that can guide future treatment choices in clinical practice.

The Department of pulmonary diseases at Universiteit Maastricht also supports research in nutritional and metabolic diseases, particularly type 2 diabetes. One trial is exploring whether changing branched-chain amino acid metabolism can help improve glucose homeostasis and lower fasting blood sugar levels.

• Research on type 2 diabetes and blood sugar regulation
• Investigation of BCAA oxidation as a way to improve metabolic control
• Testing a new approach to support glucose-lowering strategies

This line of research aims to deepen understanding of how metabolism influences diabetes and may open the door to better diagnostic and treatment approaches.